Search results
What's driving the Nifty IT Index rally in the past few days?
CNBC Awaaz· 5 hours agoIndian IT sector’s long pending recovery, hopes of Fed rate cuts and the growth expectations in the...
HDFC Bank positioned to gain from MSCI weight increase; here is how it fares compared to peers
CNBC Awaaz· 5 hours agoThe HDFC Bank stock's prolonged underperformance may soon end as its weightage in the benchmark MSCI...
Subscribe for Long Term Emcure Pharmaceuticals Ltd; Motilal Oswal
CNBC Awaaz· 5 hours agoMotilal Oswal, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has...
Sensex tops 80,000 level for the first time, what should be MF investors strategy?
CNBC Awaaz· 5 hours agoBSE Benchmark Sensex on July 3 touched the 80,000 mark in the intra-day trading for the first time...
Wockhardt shares skyrocket nearly 40% in five days as two crucial antibiotics inch closer to launch
CNBC Awaaz· 6 hours agoWockhardt shares have been on a skyward journey, surging close to 40 percent in five consecutive...
ICICI Lombard hits new record high on CLSA upgrade, forecasts 7% upside potential
CNBC Awaaz· 6 hours agoCLSA upgraded ICICI Lombard to 'outperform' from 'hold' and raised target price to Rs 2,000 per...
India may grant PLI-led visas for Chinese experts for only up to 6 months
CNBC Awaaz· 6 hours agoThe move to expedite the process to issue short-duration visas to technical experts from China comes...
Mega sale of Advent-backed Bharat Serums & Vaccines: Who are the 3 suitors in the final lap?
CNBC Awaaz· 6 hours ago"A consortium of Swedish private equity firm EQT and ADIA ( Abu Dhabi Investment Authority),...
Social media startup Koo to shut down after acquisition talks fail
CNBC Awaaz· 6 hours agoKoo co-founders Aprameya Radhakrishna and Mayank Bidawatka said they will now evaluate making the...
Subscribe Emcure Pharmaceuticals Ltd; Geojit Financial Service
CNBC Awaaz· 7 hours agoGeojit Financial Service, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on July 02 2024.